Long-term treatment with high-dose of sildenafil in a thalassemic patient with pulmonary hypertension

https://doi.org/10.4081/monaldi.2012.131

Authors

  • Michele Correale | opsfco@tin.it University of Foggia, Department of Cardiology, Italy.
  • Fiorella De Rosa University of Foggia, Department of Cardiology, Italy.
  • Riccardo Ieva University of Foggia, Department of Cardiology, Italy.
  • Matteo Di Biase Professor, University of Foggia, Department of Cardiology, Italy.
  • Natale Daniele Brunetti Assist Professor, University of Foggia, Department of Cardiology, Italy.

Abstract

We report a case of a 37-years-old man, affected by thalassemia major, hypogonadotropic hypogonadism, chronic HCV-hepatitis, diabetes mellitus, severe osteoporosis, prior septic pulmonary embolism and pulmonary artery hypertension was performed a long-term treatment with highdose of sildenafil (120 mg/die) with reduction of pulmonary arterial systolic pressure and of the dyspnea.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2015-12-01
Info
Issue
Section
Case Reports
Keywords:
pulmonary arterial hypertension, thalassemia major, sildenafil.
Statistics
  • Abstract views: 592

  • PDF: 324
How to Cite
Correale, Michele, Fiorella De Rosa, Riccardo Ieva, Matteo Di Biase, and Natale Daniele Brunetti. 2015. “Long-Term Treatment With High-Dose of Sildenafil in a Thalassemic Patient With Pulmonary Hypertension”. Monaldi Archives for Chest Disease 78 (2). https://doi.org/10.4081/monaldi.2012.131.

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.